Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
Vaidyane Ayurved Laboratories (NSE:MADHAVBAUG) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Vaidyane Ayurved Laboratories's EV-to-EBIT for today is
Vaidyane Ayurved Laboratories's current Enterprise Value is ₹1,656 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Vaidyane Ayurved Laboratories's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was ₹117 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Vaidyane Ayurved Laboratories's EV-to-EBITDA for today is:
Vaidyane Ayurved Laboratories's current Enterprise Value is ₹1,656 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Vaidyane Ayurved Laboratories's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was ₹178 Mil.
Vaidyane Ayurved Laboratories's current Enterprise Value is ₹1,656 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Vaidyane Ayurved Laboratories's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 was ₹1,069 Mil.
Vaidyane Ayurved Laboratories's current Enterprise Value is ₹1,656 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Vaidyane Ayurved Laboratories's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 was ₹54 Mil.
Vaidyane Ayurved Laboratories's current Enterprise Value is ₹1,656 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Vaidyane Ayurved Laboratories's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was ₹-25 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vaidyane Ayurved Laboratories Enterprise Value Related Terms
Vaidyane Ayurved Laboratories Enterprise Value Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vaidyane Ayurved Laboratories Enterprise Value Chart
NSE:MADHAVBAUG vs ZTS, UTHR: Enterprise Value Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Vaidyane Ayurved Laboratories's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vaidyane Ayurved Laboratories Enterprise Value vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Vaidyane Ayurved Laboratories's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Vaidyane Ayurved Laboratories's Enterprise Value falls into.
Vaidyane Ayurved Laboratories Enterprise Value Calculation
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vaidyane Ayurved Laboratories (NSE:MADHAVBAUG) has a Enterprise Value of ₹1,656 Mil as of Jul. 09, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Vaidyane Ayurved Laboratories and its competitors.
Is Vaidyane Ayurved Laboratories' Enterprise Value too high?
Vaidyane Ayurved Laboratories' current Enterprise Value is ₹1,656 Mil. Overall, Vaidyane Ayurved Laboratories has a GF Score™ of 82/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Vaidyane Ayurved Laboratories' Enterprise Value compare to ZTS and UTHR?
Vaidyane Ayurved Laboratories' Enterprise Value of ₹1,656 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Drug Manufacturers company?
A good Enterprise Value depends on the Drug Manufacturers industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Vaidyane Ayurved Laboratories and its competitors. Vaidyane Ayurved Laboratories's current Enterprise Value is ₹1,656 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vaidyane Ayurved Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Vaidyane Ayurved Laboratories (NSE:MADHAVBAUG) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹228.11, compared to a current price of ₹177.00 — trading 22.4% below its estimated fair value. The current Enterprise Value is ₹1,656 Mil. Vaidyane Ayurved Laboratories' overall GF Score™ is 82/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Vaidyane Ayurved Laboratories (NSE:MADHAVBAUG), the current Enterprise Value is ₹1,656 Mil as of Jul. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Vaidyane Ayurved Laboratories (NSE:MADHAVBAUG) Overvalued in 2026?
Based on GuruFocus' analysis, Vaidyane Ayurved Laboratories stock appears to be undervalued.
The current stock price of ₹177.00 is trading 22.4% below its estimated GF Value™ of ₹228.11.
GuruFocus considers Vaidyane Ayurved Laboratories to be Modestly Undervalued.
Key valuation signals for NSE:MADHAVBAUG:
Enterprise Value: ₹1,656 Mil
GF Value™: ₹228.11 vs. price of ₹177.00 (22.4% below fair value)
No single metric tells the full story. See the NSE:MADHAVBAUG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Vaidyane Ayurved Laboratories Business Description
Vaidya Sane Ayurved Laboratories Ltd is a medical service institution. The company engaged in research and development in Ayurvedic Medicines and the sale of Ayurvedic medicines & products through its various franchises and own clinics. The Company is also engaged in providing Ayurved medical professional services across its various clinics, including panchkarma and other Ayurvedic treatments through the running of an Ayurvedic Hospital. The company mainly offers treatment for health disease reversal, diabetes reversal, BP management, obesity management, and knee pain relief. The company's business is divided into three segments, i.e., Hospital Activity, Sale of Product, and Common. It derives maximum revenue from the sale of Products.
82GF Score
Get the complete analysis for NSE:MADHAVBAUG
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:MADHAVBAUG has been successfully added to your 
